• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量调整生命年模型以及随时间推移个体对健康状态和健康状况的偏好:文献系统综述

The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature.

作者信息

Tsuchiya Aki, Dolan Paul

机构信息

Centre for Well-being in Public Policy, School of Health and Related Research, University of Sheffield, Sheffield, UK.

出版信息

Med Decis Making. 2005 Jul-Aug;25(4):460-7. doi: 10.1177/0272989X05276854.

DOI:10.1177/0272989X05276854
PMID:16061898
Abstract

The numbers of quality-adjusted life years (QALYs) gained are increasingly being used to represent the gains in individual utility from treatment. This requires that the value of a health improvement to an individual is a simple product of gains in quality of life and length of life. The article reports on a systematic review of the literature on 2 issues: whether the value of a state is affected by how long the state lasts, and by states that come before or after it. It was found that individual preferences over health are influenced by the duration of health states and their sequence. However, although there is much variation across individual respondents, the assumptions tend to hold much better when valuations are aggregated across respondents, which is encouraging for economic evaluations that rely on using average (mean or median) values.

摘要

获得的质量调整生命年(QALY)数量越来越多地被用于表示治疗给个体带来的效用增益。这要求健康改善对个体的价值是生活质量增益和生命长度的简单乘积。本文报道了对关于两个问题的文献的系统综述:一种状态的价值是否受该状态持续时间的影响,以及受其之前或之后状态的影响。研究发现,个体对健康的偏好受健康状态的持续时间及其顺序的影响。然而,尽管个体受访者之间存在很大差异,但当对受访者的估值进行汇总时,这些假设往往更能成立,这对于依赖使用平均(均值或中位数)值的经济评估来说是令人鼓舞的。

相似文献

1
The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature.质量调整生命年模型以及随时间推移个体对健康状态和健康状况的偏好:文献系统综述
Med Decis Making. 2005 Jul-Aug;25(4):460-7. doi: 10.1177/0272989X05276854.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Hormonal therapies for early breast cancer: systematic review and economic evaluation.早期乳腺癌的激素疗法:系统评价与经济学评估
Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. doi: 10.3310/hta11260.
9
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

引用本文的文献

1
Measuring the positive potential value of birth in economic evaluation of perinatal interventions.在围产期干预措施的经济评估中衡量出生的正潜在价值。
Front Glob Womens Health. 2025 Jun 20;6:1492231. doi: 10.3389/fgwh.2025.1492231. eCollection 2025.
2
Optimal DCE design for modelling nonlinear time preferences in EQ-5D-5L valuation studies: exploration of data from Denmark and Peru.EQ-5D-5L 估值研究中用于模拟非线性时间偏好的最优 DCE 设计:丹麦和秘鲁数据探索
Health Qual Life Outcomes. 2025 Jun 15;23(1):62. doi: 10.1186/s12955-025-02391-x.
3
Implications of Diminishing Lifespan Marginal Utility for Valuing Equity in Cost-Effectiveness Analysis.
寿命边际效用递减对成本效益分析中公平性评估的影响
MDM Policy Pract. 2025 Jan 17;10(1):23814683241305106. doi: 10.1177/23814683241305106. eCollection 2025 Jan-Jun.
4
Justification of principles for healthcare priority setting: the relevance and roles of empirical studies exploring public values.医疗保健优先事项设定原则的正当性:探索公众价值观的实证研究的相关性及作用
J Med Ethics. 2025 Mar 26;51(4):285-292. doi: 10.1136/jme-2022-108702.
5
Reference-dependent age weighting of quality-adjusted life years.参考依赖的质量调整生命年年龄加权。
Health Econ. 2022 Dec;31(12):2515-2536. doi: 10.1002/hec.4593. Epub 2022 Sep 4.
6
Moving to Personalized Medicine Requires Personalized Health Plans.转向个性化医疗需要个性化健康计划。
J Particip Med. 2022 Aug 4;14(1):e35798. doi: 10.2196/35798.
7
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients.放化疗与单纯放疗在老年头颈部癌症患者中的成本效果及健康相关生活质量比较。
Strahlenther Onkol. 2022 Nov;198(11):1008-1015. doi: 10.1007/s00066-022-01975-6. Epub 2022 Jul 14.
8
A systematic literature review of disability weights measurement studies: evolution of methodological choices.残疾权重测量研究的系统文献综述:方法选择的演变
Arch Public Health. 2022 Mar 24;80(1):91. doi: 10.1186/s13690-022-00860-z.
9
Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.治疗效用的经济评估:阐明对一种治疗再狭窄的非侵入性手术的偏好。
Health Econ Rev. 2021 Jul 23;11(1):27. doi: 10.1186/s13561-021-00327-x.
10
The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities.一个用于评估转移性硬膜外脊髓压迫效用的自我管理开源模块的心理测量特性。
Pharmacoecon Open. 2019 Jun;3(2):197-204. doi: 10.1007/s41669-018-0092-1.